SITS-ICH Score Calculator

Clinical calculation support · Verify results before clinical use

Risk score inputs

Select the patient's pretreatment characteristics. The score is updated automatically.

0of 12 points
1
Age

Age at the time of treatment.

+1 point
2
Baseline NIH Stroke Scale (NIHSS)

Use the documented baseline NIHSS before thrombolysis.

0–2 points
3
Serum glucose

Threshold equivalent to 180 mg/dL (10.0 mmol/L).

+2 points
4
Systolic blood pressure

Pretreatment systolic blood pressure.

+1 point
5
Body weight

Weight recorded for the patient.

+1 point
6
Onset-to-treatment time

Time from symptom onset to start of thrombolytic treatment.

+1 point
7
Antiplatelet treatment before thrombolysis

Select the applicable option; combination therapy receives the higher score.

0–3 points
8
History of hypertension

Known history of hypertension.

+1 point
0of 12
SITS-sICH risk stratum
Low risk stratum
Score 0: observed sICH rate was 0.2% in the derivation cohort.

This score supports risk stratification and is not a substitute for thrombolysis eligibility criteria or clinical judgement.

About the SITS-sICH score

The SITS symptomatic intracerebral hemorrhage (sICH) risk score was developed to estimate the risk of sICH after intravenous alteplase for acute ischemic stroke. The original model was derived from 31,627 patients in the SITS International Stroke Thrombolysis Register.

The published score uses a weighted set of pretreatment characteristics and ranges from 0 to 12 points. Its outcome definition was SITS-MOST sICH: type 2 parenchymal hemorrhage accompanied by an NIHSS deterioration of at least 4 points or death.

Score interpretation strata

Total scoreStratumPublished risk detail available here
0–2LowScore 0: 0.2% observed sICH rate.
3–5AverageExact range-specific percentages not displayed.
6–8MediumExact range-specific percentages not displayed.
9–12HighScore ≥10: 14.3% observed sICH rate.

The risk estimates describe the study cohort and outcome definition; they are not a guarantee of an individual patient's outcome.

Important scope note

The SITS-sICH score is a prognostic aid for patients treated with intravenous alteplase. It must not be used alone to determine treatment eligibility, to delay time-critical treatment, or to replace current local stroke protocols.

References

Mazya M, Egido JA, Ford GA, et al.Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase: Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score. Stroke. 2012;43(6):1524–1531. DOI: 10.1161/STROKEAHA.111.644815. PubMed record.
Risk prediction models for intracranial hemorrhage in acute ischemic stroke patients receiving intravenous alteplase treatment: a systematic review.Frontiers in Neurology. 2023. Review of prediction models and risk-stratification approaches. Full text (PMC).
Clinical disclaimer: This calculator is for clinical decision support and education. It estimates risk and does not establish a diagnosis or dictate treatment. Verify patient data, apply current guideline-based eligibility criteria, and use clinical judgement. The original model's discrimination was moderate (C statistic 0.70); calibration and performance may differ across populations and sICH definitions.